Point Biopharma Global - Ownership and Business Overview

Life ScienceCompany

Point Biopharma Global Ownership

Who owns Point Biopharma Global?

Point Biopharma Global is owned by Eli Lilly. It was acquired on December 18, 2023.

Point Biopharma Global Business Overview

Where is Point Biopharma Global headquartered?

Point Biopharma Global is headquartered in Indianapolis, Indiana.

How many employees does Point Biopharma Global have?

Point Biopharma Global has 129 employees.

What sector is Point Biopharma Global in?

Point Biopharma Global is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Point Biopharma Global

Point Biopharma Global, Inc.

4850 West 78th Street,
Indianapolis, Indiana 46268
United States,
(647) 812-2417
www.pointbiopharma.com

Point Biopharma Global is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer. Point Biopharma Global is based in Indianapolis, Indiana.


 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.